Drugs under preclinical and clinical study for treatment of acute and chronic lymphoblastic leukemia

References

• Jiménez-HernándezEJaimes-ReyesEZArellano-GalindoJSurvival of Mexican children with acute lymphoblastic leukaemia under treatment with the protocol from the Dana-Farber Cancer Institute 00-01Biomed Res Int2015201557695025922837
   PubMed Web of Science ®Google Scholar
• PuiCHEvansWETreatment of acute lymphoblastic leukemiaN Engl J Med200635416617816407512
   PubMed Web of Science ®Google Scholar
• RobertsKGMullighanCGGenomics in acute lymphoblastic leukaemia: insights and treatment implicationsNat Rev Clin Oncol20151234435725781572
   PubMed Web of Science ®Google Scholar
• BorthakurGO’BrienSPharmacology and clinical potential of oblimersen sodium in the treatment of chronic lymphocytic leukemiaBlood Lymphat Cancer20122137143
   Google Scholar
• AdvaniASNew immune strategies for the treatment of acute lymphoblastic leukemia: antibodies and chimeric antigen receptorsHematology Am Soc Hematol Educ Program20132013113113724319174
   PubMed Web of Science ®Google Scholar
• NakanishiTSongYHeCAutophagy is associated with cucurbitacin D-induced apoptosis in human T cell leukemia cellsMed Oncol2016331826589606
   PubMed Web of Science ®Google Scholar
• WangZXuFYuanNRapamycin inhibits pre-B acute lymphoblastic leukemia cells by downregulating DNA and RNA polymerasesLeuk Res201438894094724939216
   PubMed Web of Science ®Google Scholar
• ZhangCRyuYKChenTZHallCPWebsterDRKangMHSynergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosisLeuk Res20123634234922137317
   PubMed Web of Science ®Google Scholar
• PilátováMŠarišskýMKutschyPCruciferous phytoalexins: antiproliferative effects in T-Jurkat leukemic cellsLeuk Res200529441542115725476
   PubMed Web of Science ®Google Scholar
• LucasDMEdwardsRBLozanskiGThe novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivoBlood2009113194656466619190247
   PubMed Web of Science ®Google Scholar
• AbdelwahabSIAbdulABMohanSZerumbone induces apoptosis in T-acute lymphoblastic leukemia cellsLeuk Res201135226827120708800
   PubMed Web of Science ®Google Scholar
• ChuangWCHoYCLiaoJWLuFJDunaliella salina exhibits an antileukemic immunity in a mouse model of WEHI3 leukemia cellsJ Agric Food Chem201462114791148725380534
   PubMed Web of Science ®Google Scholar
• WuCFKariotiARohrDBiliaAREfferthTProduction of rosmarinic acid and salvianolic acid B from callus culture of Salvia miltiorrhiza with cytotoxicity towards acute lymphoblastic leukemia cellsFood Chem201620129229726868579
   PubMed Web of Science ®Google Scholar
• HorieYNemotoHItohMKosakaHMoritaKFermented brown rice extract causes apoptotic death of human acute lymphoblastic leukemia cells via death receptor pathwayAppl Biochem Biotechnol2016178811326378011
   PubMed Web of Science ®Google Scholar
• GautamLNLingTLangWRivasFAnti-proliferative evaluation of monoterpene derivatives against leukemiaEur J Med Chem2016113758026922230
   PubMed Web of Science ®Google Scholar
• De FordCHeidersdorfBHaunFThe clerodane diterpene casearin J induces apoptosis of T-ALL cells through SERCA inhibition, oxidative stress, and interference with notch1 signalingCell Death Dis201671e207026821066
   PubMed Web of Science ®Google Scholar
• KachlanySCSchwartzABBalashovaNVAnti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cellsLeuk Res201034677778519747730
   PubMed Web of Science ®Google Scholar
• HaßCBelzKSchoenebergerHFuldaSSensitization of acute lymphoblastic leukemia cells for LCL161-induced cell death by targeting redox homeostasisBiochem Pharmacol2016105142226774450
   PubMed Web of Science ®Google Scholar
• GergesSRohdeKFuldaSCotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cellsCancer Lett2016375112713226944210
   PubMed Web of Science ®Google Scholar
• FeuserPEGasparPCJacquesAVSynthesis of ZnPc loaded poly(methyl methacrylate) nanoparticles via miniemulsion polymerization for photodynamic therapy in leukemic cellsMater Sci Eng C Mater Biol Appl20166045846626706552
   PubMed Web of Science ®Google Scholar
• TaghdisiSMDaneshNMLavaeePDouble targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticlesMater Sci Eng C Mater Biol Appl20166175376126838906
   PubMed Web of Science ®Google Scholar
• CaoJLiLChenCRNA interference-mediated silencing of NANOG leads to reduced proliferation and self-renewal, cell cycle arrest and apoptosis in T-cell acute lymphoblastic leukemia cells via the p53 signaling pathwayLeuk Res20133791170117723683786
   PubMed Web of Science ®Google Scholar
• Stanciu-HerreraCMorganCHerreraLAnti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell linesLeuk Res200832462563217706771
   PubMed Web of Science ®Google Scholar
• KatoJSatakeNO’DonnellRTAbuhayMLewisCTuscanoJMEfficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemiaLeuk Res2013371838823040543
   PubMed Web of Science ®Google Scholar
• QianLLiDMaLThe novel anti-CD19 chimeric antigen receptors with humanized scFv (single-chain variable fragment) trigger leukemia cell killingCell Immunol Epub2016314
   Web of Science ®Google Scholar
• WeeksRJLudgateJLLeMeeGMorisonIMTESTIN induces rapid death and suppresses proliferation in childhood b acute lymphoblastic leukaemia cellsPLoS One2016113e015134126985820
   PubMed Web of Science ®Google Scholar
• ZhangFHLingYWZhaiXThe effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemiaHematology201318315115723394269
   PubMed Web of Science ®Google Scholar
• RavandiFO’BrienSMCortesJELong-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome–positive acute lymphoblastic leukemiaCancer2015121234158416426308885
   PubMed Web of Science ®Google Scholar
• JabbourEKantarjianHRavandiFFirst report of a phase ii prospective study of combination of hypercvad with ponatinib in front-line therapy of patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaLancet Oncol201516151547155526432046
   PubMed Web of Science ®Google Scholar
• BargouRLeoEZugmaierGTumor regression in cancer patients by very low doses of a T cell-engaging antibodyScience200832197497718703743
   PubMed Web of Science ®Google Scholar
• ToppMSGoekbugetNZugmaierGAnti-CD19 BiTE blinatumomab induces high complete remission rate and prolongs overall survival in adult patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL)ASH Annu Meet Abstr2012120670
   Google Scholar
• ThomasXProfile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemiaBlood Lymphat Cancer2014201418
   Google Scholar
• KantarjianHMLioureBKimSKA phase II study of coltuximab ravtansine (SAR3419) monotherapy in patients with relapsed or refractory acute lymphoblastic leukemiaClin Lymphoma Myeloma Leuk201616313914526775883
   PubMed Web of Science ®Google Scholar
• LissitchkovTArnaudovGPeytchevDMerkleKPhase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapyJ Cancer Res Clin Oncol200513229910416292542
   PubMed Web of Science ®Google Scholar
• KnaufWULissichkovTAldaoudAPhase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemiaJ Clin Oncol2009274378438419652068
   PubMed Web of Science ®Google Scholar
• ForconiFThree years of ibrutinib in CLLBlood20151252455245625883227
   PubMed Web of Science ®Google Scholar
• HainsworthJDLitchySBartonJHSingle-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research NetworkJ Clin Oncol2003211746175112721250
   PubMed Web of Science ®Google Scholar
• JeanGWComeauJMRole of obinutuzumab in the treatment of chronic lymphocytic leukemiaAm J Health Syst Pharm20157293394225987688
   PubMed Web of Science ®Google Scholar
• MorenoCMontilloMPanayiotidisPOfatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic LeukemiaHaematologica2015100451151625596264
   PubMed Web of Science ®Google Scholar
• FurmanRRSharmanJPCoutreSEIdelalisib and rituximab in relapsed chronic lymphocytic leukemiaN Engl J Med201437011997100724450857
   PubMed Web of Science ®Google Scholar
• CerquozziSOwenCClinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemiaBiologics20159132225733804
   PubMedGoogle Scholar
• BrownJRO’BrienSKingsleyCDObinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trialBlood20151252779278525769620
   PubMed Web of Science ®Google Scholar
• ByrdJCKippsTJFlinnIWPhase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemiaBlood2010115348949519843887
   PubMed Web of Science ®Google Scholar
• KippsTJEradatHGrosickiSA phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemiaLeuk Lymphoma20151218
   Google Scholar
• BrownJRTesarBYuLObatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemiaLeuk Lymphoma20151817
   Google Scholar